|
advertisement
|
news roundup
According to a new report from eClinical Solutions and Tufts CSDD, the increasing volume and diversity of external data sources is contributing to longer database lock cycle times. Other findings from their study include that over two-thirds of sponsors are using or piloting at least four types of data in clinical trials; and only one-third of sponsors have implemented a formal data strategy.
Science 37, a provider of decentralized clinical trials services, has introduced native support for iOS and Android operating systems, for patients to learn more about a study, provide consent, schedule and participate in study visits, complete assessments, and more within a single platform.
|
|
|
advertisement
Virtual, Decentralized, Site-less Trials… What Does it All Mean?
Thursday, March 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register now
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
advertisement
Three Key Critical Considerations Before Embarking on Decentralized Trials
Available on Demand
Click here to register
|
|
|
|
|
|
|
|
|
|
Articles |
|
Clinical Research Malaysia (CRM), a research organization founded by the Malaysia Ministry of Health (MOH), shares the results of its GCP refresher workshops for clinicians, nurses, allied health professionals, and study coordinators who have been certified with Malaysian GCP. |
In this article, the authors detail the ICH E9 guidance addressing statistical methods for use in clinical trials, which outlined a structured statistical framework based on the use of estimands for use in clinical trials, released in November 2019. The objective of the estimand framework is "to align the clinical study objective with the study design, endpoint, and analysis to improve study planning and the interpretation of analysis."
|
|
advertisement
AI in Action: Clinical Development AI Use Cases
Access an online resource with useful tools and practical information about advances in RBM. The site provides useful white papers, articles, webcasts, and more.
Register now
Blog Posts
In this opinion, Editor Lisa Henderson discusses a drop in the use of consumer gene testing kits, and what this could mean to the future uses of genetic data in clinical trials.
|
|
 |
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|
